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Cioob~q MODELS of neoplasia indi-
cate a stepwise serie5 of events as the 
usual mechanism b~ which normal cells 
become neoplastic cells. I However, ca ncer 
clinically presents as a full~ malignant lesion 
capable of causing the death of the host. For 
this reason, it is presently not possible to trace 
the entire process that led to this conditIon. 
The occurrence of lymph0proliferativc dis-
orders in immunosuppressed transplant recip-
ients holds significant promise that a model of 
the early stages of neopbsia might exist in 
humans. These lesions. originally interpreted 
as .non-Hodgkin's lymphomas. occur in asso-
ciation with Epstein- Barr virus infection in 
most cases." Both pol~clonal and monoclonal 
forms have been described_D~ 
We previously observed that a significant 
number of posttransplant Iymphoproliferative 
disorders (PTLDs) seen in association with 
cyclosporine A(CsA )-steroid immunosup-
pression were capable of regression after a 
reduction of immunosuppression. H 
Our continuing studies are designed to 
explore the limits of this phenomenon and 
define the host:tumor factors that are opera-
tive within this system. The present report 
describes a retrospective clonal analysis of 
tumor tissues by using recombinant D'A 
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probes ~recific for the immunoglobulin h 
chain reg.ion. 
MATERIALS AND METHODS 
FOrl,·four patient~ in the millsburgh·aen~er 
pi3n, '>ene;. recwed diagnO'>e;. of PTLD, be:"ee; 
19S(1 and March I9g7 Clonal desrgna:ior. "'as . 
orll!;ngjj~ on the re~ultI of fmmunopero~_ida;Ke ~ya:~:;" 
c~ 10p12SmlC Immu nc)globulim In paraffin·embed~eC 
sue> The 3\·idin·blc)tln melh:x! of Hsu et ai' "as 
bined ... it~I pronase dl~esyion Antibodies of , • 
immunogic)bul,n light chams .. ere obtained frorr . 
Corp ISant;: Ba;bara. CA) 
T ... ent~-three pallents ... hose lesions "ere SlUCee ~ 
th" l~chn"lue al,c' had suffiCient !Issue 3\allab.c !fIr 
clona! anaIY;'I" of B celb bl using recombinant (J,,,, 
me: hEldolog~ 
D' A purlflCati.:m and Ie'>lrlction end(,nucie<;" t. 
Southern blot analyses ... ere performed In ~cc£>rtD·I_ 
",ith protocols pre"iously described from our laboralOl'). 
Frozen tissue specimens ..... ere pulverized in df) iq, 
freeze-dried. and solubilized in standard lysing solutioa 
before routine purification' High-molecular "elPi 
D"A was digested .,nth BamHI ...... hlch optimal!\ dD-
pla~ed hea\'\-chain gene rearran~ements The :~mboK 
nant D'A probe for the JOining region of the Imm~oogl<i­
builn hean-chain gene U,I "a~ bndl~ s:;pplreG bl Dr 
Phdlr Leder. Hanard L "Iyerpil~ 10 -
RESULTS 
PatienT Population 
The group of 44 patients was composed of 
30 males and 14 females (2.1:1). Ages at 
transplant ranged from 1 to S~ years. with a 
mean age of 23 years. There were 24 li'er. ;~ . 
kidne~K 5 heart. and 3 heart/lung recipientsir. 
the popula tion who accounted for 2.2Sf. gKl~K 
1.8s(. and 4.6S( of the respective organ allo-
graft subpopulations. Two patients jnitiall~ 
received non-CsA-<:ontaining immunosur-
pressive regimens. Tumors in these patgent~ 
occurred at 68 and 162 months posttrPn~­
plant. In the remainder of the population CsA 
was part of the original immunosuppressive 
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in thi~ subgroup of 42 
at time inten'als ranging 
I month up 10 26 monlhs 
.".n . f t The mean tlme 0 tumor Mn~e 
r was 6.2 months. ,rou .. r 
reported. the majority 0 
I'dence of either primary or cv ..' II 
Epstein-Barr vIrus Infection. 
"ration 
latian of PTLD was localized to 
and neck region in 14 patients Theis 
often manifested as a mononucl~-
,-_.Ar-r,rnr with marked tonsillar hyper-
a cervical mass. Eleven patients 
predominant in or localized to the 
tract. A third category of 
.d solid organ involvement. In many 
. lOIid organ presentation. the allograft 
invohed by the process. A su bca te-
patients in this group presented .... ith 
multIsystem disease. Eight other 
presented with a variety of findings 
rrom vague constit utional disorders to 
may exist predominantly as tumor-
infiltrative processes. In typical cases 
inant cell has features of a B 
-,,,,,'L<; All histological stages of Iympho-
maturation may be seen. a condition 
to as polymorphous or pleomorphic . 
. a monomorphous appearance in 
all cells appear identical to each other 
be seen. The lesions often sho" extensive 
of necrosis and may contain large atypi-
ring I:-mphoid cells. 
using a combination of immunocyto-
I and recombinant D!'.:A methodolo-
we have concluded that tumors were 
1anf~1KDyn"l in 12 patients. polyclonal in 15 
ts, and both monoclonal and polyclonal 
_DCOlntIgUCus) in four patients. One patient 
a polyclonal tumor that later evolved into 
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a pr~~bgble munoclonal tumor. Clonal stalu~ 
has n\.11 ~Cf been ap~lgned in 11 C;gse~K 
Ir 2.' CP~t:~ both Immunopcro,idase studic~ 
and immun,1globulln heav)-chain gene rear-
rangement studle~ were performed A repre-
sentati\c autoradiogram is shown in Fig I. 
Five case~ '>'-ere categorized as monoclonal 
by immunocytochemical stain All five were 
also shown to be monoclonal by Dl"A analy-
sis. In contrast, ten cases demonstrated a 
polyclonal phenotype by immunoperoxidase 
By using a~A analysis two of these cases 
were s.ho" n to contain a monoclonal element. 
Six other cases" ere inconclusive on the basis 
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Fig 1. Autoradi~ram demonstrating heavy-chain 
immunoglobulin gene r.arrang.ment. Banda in each 
Lara rapr ... nt DNA hybridized to the Labal.d J. probe. 
LN .. DNA ,.",as 85 • control to define unraarranged 
(polycionall P4nern, lanas I. D. D. and J show P4nern, 
obtained whan using DNA obtained from tumor .peci-
men •. The extra band in Lane J indicatea tha presenca of 
• clone of c.n. with e singl. he.vy-chain gen. rear-
rangemant. Th. other lanes show • germline band 
p.ttern. kb. kilobs .. ; G. germlin •. 
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of Immunoglobulin light-chain staim D' ..... 
rearrangement patterns revealed five of the~e 
cases to be polydonal and one to be monoclo-
nal. 
On occasion. multiple tumors were ana-
lyzed b~ one technique but not by another. 
Two cases categorized as polyclonal b~ pheno-
type had separate tumors analyzed by DNA 
probes. In both cases monoclonal tumors were 
uncovered. The converse situation was 
obtained in two cases in which additional 
tissue was available for immunoglobulin 
staining. Two cases categorized as either 
monoclonal or polyclonal on the basis of 
heav~-chain gene rearrangement analysis 
were each show n to have had separate mono-
clonal and po!yclonal tumors when separate 
specimens were stained for immunoglobulin 
light chains. 
Correlation of Histology and Clonality 
A full description of the histological aspects 
ofCsA-associated PTLDs is in preparation. In 
brief. a pleomorphic histology was associated 
with polyclonality in most but not all cases. 
Occasional pleomorphic cases contained a 
monoclonal component. In contrast. a 
monomorphous histology invariably implied a 
monoclonal tumor. In some cases. minimal 
pleomorphism was seen in association with 
prominent plasmacytoid features. These Ie· 
sions were frequently associated with mono-
clonalit). 
Survival 
Seven of 12 patients with monoclonal dis-
ease are alive at intervals ranging from 7 to 58 
months after diagnosis. Only one of the seven 
received chemotherapy in the initial thera· 
peutic regimen. There have been two cases of 
recurrence in these seven patients. One case of 
persistently recurrent disease was subse-
quently treated with chemotherapy. Another 
case resolved after reduction of immunosup-
pression. Five of 12 patients with monoclonal 
tumor died. one despite the use of chemother· 
apy. 
. Resolution of pol~clonallesion!> Was sc.:. 
nIne of II cases. One patient required 
quent radiotherar~ for control of a 
morphologically consistent with 
disease. The remainder of the nine pa . 
responded to a reduction of immunosu 
sian. Two of the nine later died of other 
with no evidence of tumor. One patient 
recurrent polyclonal disease that 
resolved. One patient developed u 
'" idespread. presumably monoclonal 
and died of aspergillosis in aSSOCiation 
chemotherap) . 
The 5-year ~~rviyDal rat~ for the entire ~ 
of 44 patlents IS 63c:;.. No dIfference is SCQ 
when these figures are segregated aCClrt~ 
to donality. 
DISCUSSION 
The increased inCidence of lymphoproEfer. 
ative disorders in transplant patients was ~nt 
recognized by StaTZI in 1968. 12 Purtilc 5:s: 
suggested that Epstein-Barr virus might ;:00-
tribute to this disQrder. 1l This was found:: be 
the case in studies of transplant patients a~:be 
Cniversity of Minnesota. 2 
These prior studies were based on patients 
receiving conventional immunosuppress,on 
Differences in tumor localization. tumor M~ 
time. and reyersibilit~ of tumors are ~rK 
when CsA-containing immunosuppres,;\e 
regimens are used. IO 
The present studies indicate that bott 
monoclonal and polyclonal tumors OCCLr it 
association with CsA immunosuppres,jo:: 
Analysis of immunoglobulin genes is shOll;) ~c 
be a more sensitive indicator of clonal S:2tus 
than is analysis of cytoplasmic immunogicbu-
lin expression. 
It is important to emphasize that dona. 
status alone does not constitute the dividing 
line between benign and malignant lesior:$ ir 
these cases. In our experience modulation of 
immunosuppression results in resolution of 
most polydonal lesions and some monocluna: 
lesions. The lack of response in some cases 
:DM1~clonal lesion~ ~as stet! 
One patient r~tK;ired 
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-I-D~K reRee! the fact that lherar~ ~as started majority of ca!De~ ~ill respond to a c;Heful 
, ""'\Jle 111 the Cl1urse of the dl~e;gse Indeed. reduction of i~munosurrrc<;Dion ~ ith contrul 
, -. r.s ~lDre aslikel) 10 die from iter~ helm· of local complicalion~I Aggrcs~:yDe chern other· 
, ~yclE1nal disease as frl)m oyerwhel~lfng ary in these immunosuppressed patient~ 
~fonai disea~e (Starzl et a1. unpubhshed should only be used In those rare cases in 
........- ~hich tumor cannot be controlled by other <~y distinct minorit:- of cases it is likel) means. 
,:,;tT- the tumor had progressed to a stage that The ultimate lessons of these lesions ha\'e 
. " .. I~ it beyond the ,reach of host control not yet been realized. It is likely thaI con· 
-~nismsI Prospectl\e studies are under tinued studies of PTLDs will reveal important 
" to identify additional factors that contrib- underlying mechanisms of immunosurveil-
::: 10 the fully developed malignant pheno- lance and tumor progression in the human, 
>. in these tumors, Thus the importance of PTLDs ma) be far in "D~Dfbc clinician caring for a transplant patient excess of their sporadic occurrence in this 
K:;~ this syndrome should be aware that the highly select group of patients, 
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